Oncologic Impact of Pancreatic Fistula

NCT04348084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 382

Last updated 2020-04-16

No results posted yet for this study

Summary

Clinically-relevant post-operative fistula is a major complication after DP, but it did not affect post-operative therapeutic path nor oncologic long-term outcomes. CR-POPF was not a predictive factor for disease recurrence and it was not associated with an increased incidence of peritoneal or local relapse.

Conditions

  • PDAC of the Body and the Tail of the Pancreas
  • CR- POPF

Sponsors & Collaborators

  • IRCCS San Raffaele

    collaborator OTHER
  • Cisanello University Hospital (Pisa, Italy)

    collaborator UNKNOWN
  • Reims University Hospital (Reims, France)

    collaborator UNKNOWN
  • Rennes University Hospital, Rennes, France

    collaborator UNKNOWN
  • Morgagni Pierantoni Hospital

    collaborator OTHER
  • Fondazione Poliambulanza Hospital (Brescia, Italy)

    collaborator UNKNOWN
  • Grenoble Alpes University Hospital (Grenoble, France)

    collaborator UNKNOWN
  • SS. Antonio e Biagio e Cesare Arrigo Hospital (Alessandria, Italy)

    collaborator UNKNOWN
  • University of Bari

    collaborator OTHER
  • IHU Strasbourg (Strasbourg, France)

    collaborator UNKNOWN
  • Hospital Centre of Luxemburg (Luxemburg)

    collaborator UNKNOWN
  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Fabrizio PANARO, PhD · UH MONTPELLIER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-30
Primary Completion
2018-12-01
Completion
2018-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04348084 on ClinicalTrials.gov